Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

GlycoMimetics Inc

GLYC
Current price
0.23 USD +0.0057 USD (+2.58%)
Last closed 0.18 USD
ISIN US38000Q1022
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 386 600 USD
Yield for 12 month -87.79 %
1Y
3Y
5Y
10Y
15Y
GLYC
21.11.2021 - 28.11.2021

GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland. Address: P.O. Box 65, Monrovia, MD, United States, 21770

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+10 000 USD

Current Quarter

Last Quarter

Current Year

Last Year

+10 000 USD

Current Quarter

Last Quarter

Key Figures GLYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -32 473 900 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -72.04 %
PEG Ratio
Return On Equity TTM -173.25 %
Wall Street Target Price 1.00 USD
Revenue TTM 10 000 USD
Book Value 0.082 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM 10 000 USD
Earnings per share -0.59 USD
Diluted Eps TTM -0.59 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GLYC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History GLYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation GLYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 555.40
Price Sales TTM 1 095.16
Enterprise Value EBITDA -0.48
Price Book MRQ 2.71

Financials GLYC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GLYC

For 52 weeks

0.14 USD 2.05 USD
50 Day MA 0.25 USD
Shares Short Prior Month 2 579 737
200 Day MA 0.25 USD
Short Ratio 9.85
Shares Short 2 464 671
Short Percent 4.62 %